A new week and a new month for BIEL. How much dilution will the Whelans push through this week? What about this month? Here's what I think:
My short term prediction:
(1) If the pps climbs a little higher over the next few days based on investor speculation of FDA reclassification and OTC approval coming closer, shortly after we will see a day with volume 10x what it normally is, and a close deep in the red. That will be Whelans diluting as usual. Rinse and repeat.
(2) If the pps fails to climb a little higher on its own, then expect a PR from BIEL informing of new markets in far away places, and how reclassification and OTC approval is just around the corner. This will in turn lead to the pps climbing a little higher over the following few days based on investor speculation, and shortly after we'll see a day with volume 10x what it normally is, and a close deep in the red. That will be Whelans diluting as usual.
So can you see the common factor there? If you do, then good for you! You're in the minority it seems.
My long term prediction:
Once the pps hits the 0.000X level, or FDA reclassification actually becomes a reality and pushes the pps up significantly, BIEL will push out a flurry of PRs and then in the middle of it quietly announce a HUGE reverse split that will leave most here reeling. At that poinst the clock is reset as far as the Whelans are concerned, and the dilution starts anew for another few years until the pps gets back down to the current levels with similarly high o/s. The Whelan's business, imho, is primarily to harvest as much cash out of this as possible. The BIEL product is secondary, and serves mostly as a means to achieve their primary objective.
What you need to know about BIEL:
MASSIVE dilution, no significant revenues at all, YEARS of PR's about dozens of new distribution agreements all over the world yet still no significant revenues generated from any of them. Expensive trips to multiple overseas destinations like Monte Carlo for the CEO and his friends (aka distributors, lol) all on the shareholder's dime, questionable financing with 'finance' companies in family member's names set up from shell companies. Claims of reclassification and FDA OTC approval "right around the corner" have been touted for YEARS but they never materialize. This stock absolutely REEKS of being nothing but a cash machine for the CEO's family at the expense of shareholders imo. Come on - SIX BILLION SHARES now - and a 95+% drop in share value over the last 5 years! Repeated fluff PR's to pump, immediately followed by dilution, over and over and over and over and over and over and over and over again.. Even if the science behind the product were sound, the way this company is milking shareholders with no ROI is atrocious. My opinion: cut your losses now and run, because year after year after year after year after year of history here shows a continued pattern of PR and dilution without letup, and there is no sign of that changing anytime soon, imo.
